It has been found in a recent report that the company supplying now obsolete PIP breast implants has again been suspected to restructure itself.

An inspection conducted by a senate committee has revealed that Medical Vision Australia in attempt to avoid compensating victims has been shaking itself up.

The committee was inquiring the French-manufactured silicone gel breast implants as well as their regulation by the Therapeutic Goods Administration. The report has found that the Adelaide-based medical device business had refused to come for the inquiry by the committee. Also, it had failed to report properly about the product to the TGA.

It is thus that the inquirers have been suspecting that the company’s reform into two separate companies in December last year was the possible outcome of fears related to the implants. "It would have been very useful for MVA to state on the record the reasons for this split, and the impact this split may have on individuals seeking legal redress”, said independent Senator Nick Xenophon.

The report has also found that nearly 950 women through the country have contacted the firm and they were never informed that implants could be faulty also. Therefore, law firm Tindall Gask Bentley has fronted an action against it on behalf of those women.